Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma (CCRT-VIDL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01007526
Recruitment Status : Unknown
Verified May 2012 by Won Seog Kim, Samsung Medical Center.
Recruitment status was:  Recruiting
First Posted : November 4, 2009
Last Update Posted : May 24, 2012
Asan Medical Center
National Cancer Center, Korea
Severance Hospital
Information provided by (Responsible Party):
Won Seog Kim, Samsung Medical Center

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2012
  Estimated Study Completion Date : December 2012

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 December 30, 2012 February 1, 2013
2 February 10, 2013 March 13, 2013
3 June 3, 2013 July 9, 2013
4 October 25, 2017